Letter to the Editor: Stem Cell Politics
By Richard Hayes,
New York Times
| 05. 01. 2006
To the Editor:
Re "Democrats Hope to Divide G.O.P. Over Stem Cells" (news article, April 24):
I'm a lifelong Democrat, pro-choice on abortion and in favor of stem cell research. But over-the-top promotion of this research is a mistake that could come back to bite us, and its use as a wedge issue is ill advised.
Stem cells may still prove to be a therapeutic dry hole. If successfully developed, stem cell therapies are likely to be prohibitively expensive.
Stem cell research puts women who donate eggs at significant medical risk, and could foster trafficking in eggs from poor women in developing countries.
The same stem cell technologies that might have beneficial medical applications could be used by rogue scientists intent on creating human clones and genetically modified children.
Stem cell research should be allowed, but it should proceed cautiously, under tight federal oversight.
Richard Hayes
Executive Director
Center for Genetics and Society
Oakland, Calif., April 24, 2006
Related Articles
By staff, Japan Times | 12.04.2025
Japan plans to introduce a ban with penalties on implanting a genome-edited fertilized human egg into the womb of a human or another animal amid concerns over "designer babies."
A government expert panel broadly approved a proposal, including the ban...
By Katherine Long, Ben Foldy, and Lingling Wei, The Wall Street Journal | 12.13.2025
Inside a closed Los Angeles courtroom, something wasn’t right.
Clerks working for family court Judge Amy Pellman were reviewing routine surrogacy petitions when they spotted an unusual pattern: the same name, again and again.
A Chinese billionaire was seeking parental...
By Sarah A. Topol, The New York Times Magazine | 12.14.2025
The women in House 3 rarely had a chance to speak to the women in House 5, but when they did, the things they heard scared them. They didn’t actually know where House 5 was, only that it was huge...
By Frankie Fattorini, Pharmaceutical Technology | 12.02.2025
Próspera, a charter city on Roatán island in Honduras, hosts two biotechs working to combat ageing through gene therapy, as the organisation behind the city advertises its “flexible” regulatory jurisdiction to attract more developers.
In 2021, Minicircle set up a...
